Inflammatory bowel disease in pediatrics

Darmadi Darmadi; Riska Habriel Ruslie

doi:10.5455/rmj20220813013434

Abstract
Inflammatory bowel disease (IBD) comprises of Crohn’s disease (CD) and ulcerative colitis (UC). This is a chronic inflammation involving gastrointestinal tract. The prevalence of IBD is increasing recently. Approximately, 25% of all IBD cases develope during childhood. Intrinsic and extrinsic factors play important role in the pathogenesis of IBD. Mild form of IBD is more common in children with symptoms ranging from weight loss, rectal bleeding, diarrhea, and abdominal pain. Diagnosis is established based on history, physical examination, laboratory examination, imaging, endoscopy and colonoscopy, and ultimately, histopathology examination. Management includes utilization of aminosalicylates, corticosteroids, immunomodulators, and biologic agents. Nutritional support, psychosocial approach and surgical approach are other therapeutic options. The complications may occur such as micronutrient deficiency, growth failure, increased risk of malignancies, and psychiatric disorders. Routine monitoring of disease progress and growth achievement is mandatory in the management of IBD.

Key words: Colitis, Crohn’s disease, inflammatory bowel disease, pediatric.

ABOUT JOURNAL About Publisher Contact Us Editorial & Peer Review Process	POLICIES Privacy Policy Editorial Policy Author's Rights and Obligations Conflict of Interest Policy Plagiarism Policy Advertising Policy	STATEMENTS Terms of Use Author's Rights and Obligations Publication Ethics and Publication Malpractice Statement Protection of Research Participants (Statement On Human And Animal Rights) License Information

This is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles in this journal without asking prior permission from the publisher or the author. This is in accordance with the Budapest Open Access Initiative (BOAI) definition of open access. The articles in Rawal Medical Journal are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.

Indexed in Scopus, Web of Science, WHO Index Medicus IMEMR, Emromedex, Pakmedinet, ExtraMED and Tehqeeqat

How to cite this article

	Open Access and Peer-reviewed
Home Journal Issues Guide for Authors Editorial Board Aims & Scope About Journal News & Announcements